Catalog No.:AA01EOPX

1132936-00-5 | (E)-N-(4-(3-(tert-Butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide

Name: Name:(E)-N-(4-(3-(tert-Butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide
Brand: AABLOCKS
SKU: AA01EOPX
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

99%

1 week

$447.00 $313.00

- +

5mg

99%

1 week

$844.00 $591.00

- +

10mg

99%

1 week

$1,320.00 $924.00

- +

25mg

99%

1 week

$2,828.00 $1,980.00

- +

50mg

99%

1 week

$4,495.00 $3,147.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA01EOPX

Chemical Name:

(E)-N-(4-(3-(tert-Butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide

CAS Number:

1132936-00-5

Molecular Formula:

C24H27N3O5S

Molecular Weight:

469.5533

MDL Number:

MFCD28502074

SMILES:

COc1c(/C=C/c2ccc(cc2)NS(=O)(=O)C)cc(cc1C(C)(C)C)n1ccc(=O)[nH]c1=O

Properties

Computed Properties

Complexity:

879

Covalently-Bonded Unit Count:

Defined Bond Stereocenter Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

3.6

Literature

Title: Lawitz E, et al. A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. J Hepatol. 2013;59(1):18-23.

Title: Shi Y, et al. Assessing Supersaturation and Its Impact on In Vivo Bioavailability of a Low-Solubility Compound ABT-072 With a Dual pH, Two-Phase Dissolution Method. J Pharm Sci. 2016;105(9):2886-2895.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS